Skip to main content

Holiday schedule

Our Patient Service Centers will be closed on Monday, May 27, 2024 for the Memorial Day holiday. Have a healthy, happy holiday.


Get the right leukemia insights with our broad testing portfolio

Whether you need peripheral blood panels, a comprehensive diagnosis on a bone marrow biopsy, or a “hard to find” molecular assay, we power innovative solutions to address the specific needs of your practice or laboratory with our comprehensive menu of routine and specialized hematopathology testing services.

Acute Myeloid Leukemia (AML)

Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow that progresses very quickly. Therefore, prompt diagnosis improves outcomes.

Acute lymphocytic leukemia (ALL)

Quest Diagnostics employs the FISH panel to identify the TEL/AML1 gene fusion that is usually undetectable by conventional chromosome analysis used to screen for acute lymphoblastic leukemia (ALL).

Chronic lymphocytic leukemia (CLL)

Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. In some cases, the disease can be aggressive and within a year the tumor mass may increase significantly imposing serious health problems to the patient.

Chronic myeloid leukemia (CML)

Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It's a type of cancer that starts in certain blood-forming cells of the bone marrow.1

Comprehensive hematology solutions for your patient’s journey

The breadth of our hematology testing is designed to provide important diagnostic insights to you and your patients at every stage of their cancer diagnosis, care, and management.

Our comprehensive testing portfolio ranges from broad diagnostic tools like CBCs and LeukoVantage®, to targeted solutions like AML Rapid Mutation Panel, to empower you with timely, informed insights about your patient’s disease.

Leukemia tests

This information is provided for informational purposes only and is not intended as medical advice. A physician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.




  1. American Cancer Society. What Is chronic myeloid leukemia? Updated June 19, 2018. Accessed August 4, 2021.